Besunyen Holdings Co. Ltd. (HK:0926)
:0926
Want to see HK:0926 full AI Analyst Report?
Top Page
Besunyen Holdings Co. Ltd.
(0926)
Select Model
Select Model
Rating:66Neutral
Price Target:
HK$2.50
▼(-3.85% Downside)
Action:Reiterated
Date:05/11/26
The score is driven primarily by improved profitability and stronger recent free cash flow with a conservative, low-debt balance sheet. Offsetting this is significant top-line contraction that clouds the durability of the turnaround. Valuation is supportive (low P/E and very high dividend yield), while technicals are only moderately positive.
Positive Factors
Conservative balance sheet
A very low debt load gives the company durable financial flexibility to absorb shocks, fund operations or targeted investments, and maintain distributions. Over a 2–6 month horizon this reduces refinancing risk and supports strategic options while revenue recovery is addressed.
Negative Factors
Severe revenue contraction
An extremely large reported top-line decline undermines the durability of profitability gains: falling sales erode operating leverage, threaten supplier and customer relationships, and make margin and cash improvements harder to sustain unless demand or distribution is restored.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
A very low debt load gives the company durable financial flexibility to absorb shocks, fund operations or targeted investments, and maintain distributions. Over a 2–6 month horizon this reduces refinancing risk and supports strategic options while revenue recovery is addressed.
Read all positive factors
Besunyen Holdings Co. Ltd. (0926) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$216.04M
Dividend Yield47.72%
Average Volume (3M)2.87K
Price to Earnings (P/E)12.8
Beta (1Y)0.27
Revenue Growth2.05%
EPS Growth37.85%
CountryHK
Employees128
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.17
Shares Outstanding122,265,590
10 Day Avg. Volume825
30 Day Avg. Volume2,871
Financial Highlights & Ratios
PEG Ratio0.31
Price to Book (P/B)0.56
Price to Sales (P/S)0.53
P/FCF Ratio4.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Besunyen Holdings Co. Ltd. Business Overview & Revenue Model
Company Description
Besunyen Holdings Company Limited engages in the research and development, production, and sale of therapeutic tea products and pharmaceuticals in the People's Republic of China. It offers its therapeutic tea products under the Besunyen brand; her...
Besunyen Holdings Co. Ltd. Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
82
Very Positive
Cash Flow
64
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 494.32M | 484.30M | 542.88M | 801.34M | 1.10B |
| Gross Profit | 346.58M | 325.84M | 346.22M | 492.59M | 698.55M |
| EBITDA | 49.87M | 33.89M | -124.31M | -8.72M | -11.98M |
| Net Income | 20.44M | 14.80M | -299.24M | -99.09M | -145.71M |
Balance Sheet | |||||
| Total Assets | 563.54M | 560.69M | 704.94M | 1.54B | 1.64B |
| Cash, Cash Equivalents and Short-Term Investments | 178.00M | 174.70M | 252.79M | 437.99M | 226.60M |
| Total Debt | 4.94M | 5.68M | 5.11M | 194.89M | 286.61M |
| Total Liabilities | 93.16M | 85.32M | 150.97M | 484.73M | 586.74M |
| Stockholders Equity | 468.47M | 475.38M | 553.97M | 854.34M | 827.52M |
Cash Flow | |||||
| Free Cash Flow | 60.12M | 5.54M | 3.19M | -16.50M | -278.19M |
| Operating Cash Flow | 66.04M | 10.54M | 9.98M | 38.11M | -145.52M |
| Investing Cash Flow | 8.55M | 59.36M | 8.39M | -35.49M | -188.35M |
| Financing Cash Flow | -32.06M | -103.84M | -81.12M | 12.49M | 6.32M |
Besunyen Holdings Co. Ltd. Technical Analysis
Negative
2.60
Price Trends
2.47
Negative
2.50
Negative
2.54
Negative
Market Momentum
>-0.01
Positive
48.03
Neutral
23.57
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0926, the sentiment is Negative. The current price of 2.6 is above the 20-day moving average (MA) of 2.47, above the 50-day MA of 2.47, and above the 200-day MA of 2.54, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 48.03 is Neutral, neither overbought nor oversold. The STOCH value of 23.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0926.
Besunyen Holdings Co. Ltd. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
88 Outperform | HK$3.30B | 8.02 | 12.93% | 3.74% | 22.72% | 41.32% | |
73 Outperform | HK$3.82B | 12.64 | 24.42% | 3.84% | -2.40% | 21.77% | |
67 Neutral | HK$550.00M | 103.17 | 7.49% | 8.95% | -31.74% | -92.61% | |
66 Neutral | HK$216.04M | 12.84 | 4.03% | 47.72% | 2.05% | 37.85% | |
65 Neutral | HK$3.04B | 21.80 | 6.90% | 3.70% | -15.05% | -11.32% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
49 Neutral | HK$8.06B | 38.56 | 3.27% | 1.77% | 10.02% | ― |
* Consumer Defensive Sector Average
HK:0926
Besunyen Holdings Co. Ltd.
2.47
0.46
23.01%
HK:1112
Health and Happiness (H&H) International Holdings
12.49
-0.51
-3.93%
HK:6868
Tenfu (Cayman) Holdings Co
2.82
-0.31
-10.05%
HK:1837
Natural Food International Holding Ltd.
1.51
0.85
128.79%
HK:1497
Xiamen Yan Palace Bird's Nest Industry Co., Ltd. Class H
6.35
0.25
4.18%
HK:2530
Numans Health Food Holdings Company Limited
0.55
-0.05
-8.33%
Besunyen Holdings Co. Ltd. Corporate Events
Besunyen Posts Higher 2025 Profit on Margin Gains, Withholds Final Dividend
Mar 22, 2026
Besunyen Holdings reported revenue of RMB494.3 million for 2025, a 2.1% increase year on year, with gross profit rising 6.4% to RMB346.6 million and gross margin expanding to 70.1%. Total operating expenses fell 1.1% to RMB314.7 million, supportin...
Besunyen Sets March Board Meeting to Approve 2025 Results and Weigh Final Dividend
Mar 9, 2026
Besunyen Holdings Company Limited has scheduled a board meeting for 20 March 2026 to review and approve the consolidated final results for the financial year ended 31 December 2025. The board will also consider whether to recommend a final dividen...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.